Among Women with prolonged rupture of membranes and fever which is better- dual antibiotic regimen or ampicillin alone?
Israel: Ampicillin in women with prolonged rupture of membranes (ROM >18h) and fever may promote the growth of ampicillin-resistant Enterobacteriaceae (including E.coli) and raises the risk of neonatal and maternal infectious morbidity compared to dual treatment; a recent study has shown. The study was published online in the Journal of Gynecology Obstetrics and Human Reproduction.
Intraamniotic infection (IAI) is an acute inflammation of the chorion and membranes of the placenta, typically due to ascending polymicrobial bacterial infection in the setting of membrane rupture. IAI risk factors include prolonged active labour>12h, meconium-stained amniotic fluid, group B streptococci (GBS) colonization, and long ROM >18h; the latter increased IAI risk by 6.9 times.
There has been an increase in the impact of E. coli in causing peripartum infections due to rising ampicillin resistance. Raneen Abu Shqara, Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel, and colleagues compared neonatal and maternal outcomes of women with prolonged ROM and intrapartum fever according to two antibiotics regimens they were administered with. They also described the bacterial distribution focusing on risk factors for Enterobacteriaceae-related infectious morbidity.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.